BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 26324033)

  • 1. Immunohistochemical Expression of HBME-1 and TROP-2 in Some Follicular-Derived Thyroid Lesions.
    Abu-Seadah SS; Attiah SM; Ali MY; Shams El-Din M; El-Kholy MA
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2305-2311. PubMed ID: 37505760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S
    Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer.
    Plantinga TS; Tesselaar MH; Morreau H; Corssmit EP; Willemsen BK; Kusters B; van Engen-van Grunsven AC; Smit JW; Netea-Maier RT
    Autophagy; 2016 Jul; 12(7):1195-205. PubMed ID: 27105307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.
    Agrati C; Castilletti C; Casetti R; Sacchi A; Falasca L; Turchi F; Tumino N; Bordoni V; Cimini E; Viola D; Lalle E; Bordi L; Lanini S; Martini F; Nicastri E; Petrosillo N; Puro V; Piacentini M; Di Caro A; Kobinger GP; Zumla A; Ippolito G; Capobianchi MR
    Cell Death Dis; 2016 Mar; 7(3):e2164. PubMed ID: 27031961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management--A Case Report.
    Shrestha RT; Karunamurthy A; Amin K; Nikiforov YE; Caramori ML
    Thyroid; 2015 Dec; 25(12):1375-8. PubMed ID: 26355276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters predicting follicular carcinoma in thyroid nodules with indeterminate cytology.
    Kunt M; Cirit E; Eray IC; Yalay O; Parsak CK; Sakmann G
    Ann Ital Chir; 2015; 86(4):301-5; discussion 306. PubMed ID: 26344173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced thyroid cancer: role of molecularly targeted therapies.
    Covell LL; Ganti AK
    Target Oncol; 2015 Sep; 10(3):311-24. PubMed ID: 26335853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.
    Englum BR; Pura J; Reed SD; Roman SA; Sosa JA; Scheri RP
    World J Surg; 2015 Dec; 39(12):2928-34. PubMed ID: 26324158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-Related Beclin 1 and Head and Neck Cancers.
    Hu YJ; Zhong JT; Gong L; Zhang SC; Zhou SH
    Onco Targets Ther; 2020; 13():6213-6227. PubMed ID: 32669852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glucose transporter-1, hypoxia inducible factor-1α and beclin-1 in head and neck cancer and their implication.
    Lin W; Yin CY; Yu Q; Zhou SH; Chai L; Fan J; Wang WD
    Int J Clin Exp Pathol; 2018; 11(7):3708-3717. PubMed ID: 31949754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBME-1 expression in differentiated thyroid carcinoma and its correlation with the ultrasonic manifestation of thyroid.
    Qiao J; Li C; Zhang Y; Wang S; Gao S
    Oncol Lett; 2017 Dec; 14(6):6505-6510. PubMed ID: 29151906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of autophagy-associated proteins in papillary thyroid carcinoma.
    Yang M; Bai L; Yu W; Sun X; Xu G; Guan R; Yang Y; Qiu M; Zhang Y; Tian J; Fang H
    Oncol Lett; 2017 Jul; 14(1):411-415. PubMed ID: 28693184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer?
    Yeşil C; Kandemir O; Haksever H; Dabakoğlu T
    Acta Chir Belg; 2015; 115(4):299-305. PubMed ID: 26324033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN; He L; Cheng JQ; Chen SC; Zhao HF; Zhai JP; Zhang J
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas.
    Rezk S; Brynes RK; Nelson V; Thein M; Patwardhan N; Fischer A; Khan A
    Endocr Pathol; 2004; 15(4):329-37. PubMed ID: 15681857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular thyroid carcinoma.
    Sobrinho-Simões M; Eloy C; Magalhães J; Lobo C; Amaro T
    Mod Pathol; 2011 Apr; 24 Suppl 2():S10-8. PubMed ID: 21455197
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.